Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro (Q43179208)

15 November 2017

Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro (English)

1 reference

15 November 2017

1 reference

C Fürnsinn

1

1 reference

15 November 2017

S Neschen

2

1 reference

15 November 2017

C Noe

3

1 reference

15 November 2017

M Bisschop

4

1 reference

15 November 2017

M Roden

5

1 reference

15 November 2017

C Vogl

6

1 reference

15 November 2017

B Schneider

7

1 reference

15 November 2017

W Waldhäusl

8

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

British Journal of Pharmacology

15 November 2017

1 reference

15 November 2017

122

1 reference

15 November 2017

7

1 reference

15 November 2017

1367-1374

1 reference

Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites

15 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Stimulation of glucose transport in skeletal muscle by hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Synergistic interaction between exercise and insulin on peripheral glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Effects of exercise on insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

New Tables for Multiple Comparisons with a Control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Causes and elimination of erratic blanks in enzymatic metabolite assays involving the use of NAD+ in alkaline hydrazine buffers: Improved conditions for the assay of l-glutamate, l-lactate, and other metabolites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Insulin-like vs. non-insulin-like stimulation of glucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Acute effects of troglitazone on in vivo insulin action in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Epinephrine-induced in vivo muscle glycogen depletion enhances insulin sensitivity of glucose transport

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

High-performance frontal analysis for the study of protein binding of troglitazone (CS-045) in albumin solution and in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Translocation of two glucose transporters in heart: effects of rotenone, uncouplers, workload, palmitate, insulin and anoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701527

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701527

1 reference

release_tfxdv3m7y5e5nlo3j7s7zsdnhq

15 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tfxdv3m7y5e5nlo3j7s7zsdnhq

24 November 2022

mapped directly with Wikidata item

1 reference

15 November 2017

PubMed publication ID

9421284

1 reference